Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-18

Clinical Trial Update: Intestinal Permeability and Intestinal Microbiota in Irritable Bowel Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining intestinal permeability and microbiota in Irritable Bowel Syndrome with Diarrhea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: I.M. Sechenov First Moscow State Medical University | Conditions: Irritable Bowel Syndrome With Diarrhea | Phase 4 | Status: UNKNOWN